ARKG vs DIVO
ARK Genomic Revolution ETF vs Amplify CWP Enhanced Dividend Income ETF
ARKG—
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: —Yield: —
DIVO—
Amplify CWP Enhanced Dividend Income ETF
Quality dividend payers with tactical covered calls.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKG | DIVO |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | Amplify |
ARKG top holdings
Holdings data unavailable for ARKG.
DIVO top holdings
Holdings data unavailable for DIVO.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology.
About DIVO
DIVO (Amplify CWP Enhanced Dividend Income ETF) is Quality dividend payers with tactical covered calls.